| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| KAPLAN GILLA | Director | C/O TYRA BIOSCIENCES, INC., 2656 STATE STREET, CARLSBAD | /s/ Ali D. Fawaz, Attorney-in-Fact | 16 Jun 2025 | 0001247024 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TYRA | Common Stock | Sale | $309,255 | -30,000 | -33% | $10.31 | 59,623 | 12 Jun 2025 | Direct | F1 |
| transaction | TYRA | Common Stock | Sale | $154,582 | -15,000 | -25% | $10.31 | 44,623 | 13 Jun 2025 | Direct | F2 |
| transaction | TYRA | Common Stock | Sale | $70,726 | -6,814 | -15% | $10.38 | 37,809 | 16 Jun 2025 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.25 to $10.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F2 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.25 to $10.43. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F3 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.35 to $10.46. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |